News

First U.S. Patients Enrolled in an Early Feasibility Study of HLT’s New Transcatheter Aortic Valve Replacement System

RADIANT clinical study evaluating safety and performance outcomes of HLT’s Meridian® Valve and Pathfinder® II Delivery System for severe aortic stenosis Read More

HLT Announces First Patient Enrollments in a Feasibility Study of a New Transcatheter Aortic Valve Replacement System

RADIANT clinical study to evaluate safety and performance outcomes of HLT’s Meridian® Valve and Pathfinder® II Delivery System for severe aortic stenosis  Read More

Bracco Supports HLT, Inc. Volunteer at Milan Expo

HLT, Inc. featured in The Gazette

HLT, Inc., Names Kevin Bassett General Manager

HLT, Inc., a medical device company developing leading edge transcatheter aortic valve replacement (TAVR) therapy, today announced the addition of Kevin Bassett as general manager.

Read More